Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

Tatva Chintan Pharma IPO Review

  1. Home>
  2. Tatva Chintan Pharma IPO Review

Tatva Chintan Pharma IPO

  • Post author:[email protected]
  • Post published:July 16, 2021
  • Post category:Uncategorized
  • Post comments:0 Comments

Tatva Chintan Pharma IPO intends to raise Rs. 500 crore through fresh issue of shares worth Rs 225 crore and an offer for sale of shares worth Rs 275 crore…

Continue ReadingTatva Chintan Pharma IPO

Archives

Categories

Copyright - WordPress Theme by OceanWP